Evidence map›Paper›PMID 20085807›Full record

ArticleBiochimica et biophysica acta2010

Hydroimidazolone modification of human alphaA-crystallin: Effect on the chaperone function and protein refolding ability.

Mahesha H Gangadhariah, Benlian Wang, Mikhail Linetsky, Christian Henning, Robert Spanneberg, Marcus A Glomb, Ram H Nagaraj

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mahesha H GangadhariahDepartment of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
Benlian Wang
Mikhail Linetsky
Christian Henning
Robert Spanneberg
Marcus A Glomb
Ram H Nagaraj
Case Western Reserve University · USMartin Luther University Halle-Wittenberg · DE

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
MAILLARD REACTIONS AND OXIDATION IN CATARACTOGENESISR01EY009912 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI NAGARAJ, RAM H · 1998 to 2012
$3.1M
Modifications of Small Heat Shock Proteins in the LensR01EY016219 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI NAGARAJ, RAM H · 2005 to 2009
$1.9M
NEI NIH HHS P30 EY011373NEI NIH HHS P30EY-11373NEI NIH HHS R01 EY009912NEI NIH HHS R01 EY016219NEI NIH HHS R01EY-016219NEI NIH HHS R01EY-09912
6 · The paper itself

Abstract

AlphaA-crystallin is a molecular chaperone; it prevents aggregation of denaturing proteins. We have previously demonstrated that upon modification by a metabolic alpha-dicarbonyl compound, methylglyoxal (MGO), alphaA-crystallin becomes a better chaperone. AlphaA-crystallin also assists in refolding of denatured proteins. Here, we have investigated the effect of mild modification of alphaA-crystallin by MGO (with 20-500 microM) on the chaperone function and its ability to refold denatured proteins. Under the conditions used, mildly modified protein contained mostly hydroimidazolone modifications. The modified protein exhibited an increase in chaperone function against thermal aggregation of beta(L)- and gamma-crystallins, citrate synthase (CS), malate dehydrogenase (MDH) and lactate dehydrogenase (LDH) and chemical aggregation of insulin. The ability of the protein to assist in refolding of chemically denatured beta(L)- and gamma-crystallins, MDH and LDH, and to prevent thermal inactivation of CS were unchanged after mild modification by MGO. Prior binding of catalytically inactive, thermally denatured MDH or the hydrophobic probe, 2-p-toluidonaphthalene-6-sulfonate (TNS) abolished the ability of alphaA-crystallin to assist in the refolding of denatured MDH. However, MGO modification of chaperone-null TNS-bound alphaA-crystallin resulted in partial regain of the chaperone function. Taken together, these results demonstrate that: 1) hydroimidazolone modifications are sufficient to enhance the chaperone function of alphaA-crystallin but such modifications do not change its ability to assist in refolding of denatured proteins, 2) the sites on the alphaA-crystallin responsible for the chaperone function and refolding are the same in the native alphaA-crystallin and 3) additional hydrophobic sites exposed upon MGO modification, which are responsible for the enhanced chaperone function, do not enhance alphaA-crystallin's ability to refold denatured proteins.

Indexed as

Protein FoldingCrystallinsHumansHydrophobic and Hydrophilic InteractionsImidazolesMolecular ChaperonesProtein DenaturationProtein Structure, TertiaryCRYAA protein, humanCrystallinsImidazolesimidazoloneMolecular Chaperones

Identifiers

PMID20085807
PMCPMC2826572
OpenAlexW2158327072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.